US FTC clarifies what constitutes product endorsement in blogs
This article was originally published in SRA
US pharmaceutical and medical device companies using endorsements and testimonials from patients or medical experts in their advertising campaigns need to pay attention to revised guidance on the topic issued by the Federal Trade Commission1-3.
You may also be interested in...
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.